# BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

> **NCT06439069** · — · RECRUITING · sponsor: **Lithuanian University of Health Sciences** · enrollment: 340 (estimated)

## Conditions studied

- Heart Failure
- Obesity

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06439069
- **Lead sponsor:** Lithuanian University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-10
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06439069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06439069, "BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06439069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*